Krokidis Marios G, Louka Maria, Efthimiadou Eleni K, Zervou Sevasti-Kiriaki, Papadopoulos Kyriakos, Hiskia Anastasia, Ferreri Carla, Chatgilialoglu Chryssostomos
Institute of Nanoscience and Nanotechnology, N.C.S.R. "Demokritos", 15310 Agia Paraskevi-Athens, Greece.
Lipidomics Laboratory, Lipinutragen srl, Via Piero Gobetti 101, 40129 Bologna, Italy.
Cancers (Basel). 2019 Apr 4;11(4):480. doi: 10.3390/cancers11040480.
Increased rates of reactive oxygen/nitrogen species (ROS/RNS) are involved in almost all cancer types, associated with tumor development and progression, causing damage to biomolecules such as proteins, nucleic acids and membrane lipids, in different biological compartments. We used a human tumor xenograft mouse model to evaluate for the first time in parallel the remodeling of fatty acid moieties in erythrocyte membrane phospholipids and the level of ROS-induced DNA lesions in liver and kidney tissues. Using liquid chromatography tandem mass spectrometry the 5' and 5' diastereoisomers of 5',8-cyclo-2'-deoxyadenosine and 5',8-cyclo-2'-deoxyguanosine, together with 8-oxo-7,8-dihydro-2'-deoxyadenosine, were determined in mice at young (4- and 5-weeks) and old (17-weeks) ages and compared with control SCID mice without tumor implantation. Tumor-bearing mice showed a higher level of ROS-damaged nucleosides in genomic DNA as the age and tumor progress, compared to controls (1.07-1.53-fold in liver and 1.1-1.4-fold in kidney, respectively). The parallel fatty acid profile of erythrocyte membranes showed a profound lipid remodeling during tumor and age progression consisting of PUFA consumption and SFA enrichment (ca 28% and 58%, respectively, in late stage tumor-bearing mice), markers of enhanced oxidative and proliferative processes, respectively. Membrane lipid remodeling and ROS-induced DNA lesions may be combined to afford an integrated scenario of cancer progression and ageing, reinforcing a holistic vision among molecular markers rather than the biomarker identification in a single compartment.
活性氧/氮物种(ROS/RNS)生成速率增加几乎涉及所有癌症类型,与肿瘤发生和进展相关,会在不同生物区室对蛋白质、核酸和膜脂等生物分子造成损伤。我们使用人肿瘤异种移植小鼠模型,首次同时评估红细胞膜磷脂中脂肪酸部分的重塑以及肝脏和肾脏组织中ROS诱导DNA损伤的水平。利用液相色谱串联质谱法测定了年轻(4周和5周)和老年(17周)小鼠体内5',8-环-2'-脱氧腺苷和5',8-环-2'-脱氧鸟苷的5'和5'非对映异构体,以及8-氧代-7,8-二氢-2'-脱氧腺苷,并与未植入肿瘤的对照SCID小鼠进行比较。与对照组相比,荷瘤小鼠基因组DNA中ROS损伤核苷的水平随年龄和肿瘤进展而升高(肝脏中分别为1.07 - 1.53倍,肾脏中为1.1 - 1.4倍)。红细胞膜的平行脂肪酸谱显示,在肿瘤和年龄进展过程中发生了深刻的脂质重塑,包括多不饱和脂肪酸(PUFA)消耗和饱和脂肪酸(SFA)富集(晚期荷瘤小鼠中分别约为28%和58%),分别是氧化和增殖过程增强的标志。膜脂质重塑和ROS诱导的DNA损伤可能共同构成癌症进展和衰老的综合情况,强化了分子标记之间的整体观点,而非单个区室中的生物标志物识别。